English
Chinese (Simplified)
French
Portuguese
Spanish
German
Forward
Print
Comment
Molecular Imaging Homepage
GE to provide training to at least 140 Kenyan radiographers Partnering with Society of Radiography in Kenya
NorthStar, Shine in line for federal funding Bringing $20 million in additional funding to domestic moly-99 in the US
Adel Abdullah and Aaron Hargrave Positron appoints president and vice president
Theranostics – Nuclear medicine´s fountain of youth Combining therapeutics with diagnostics, opportunities and challenges
New House bill calls for change in CMS definition of radiopharmaceuticals Reimburse separately instead of as bundled payment
Cerveau Technologies partners with Ionis Pharmaceuticals Use of PET agent, [F-18]MK-6240
New PET imaging method may yield benefits over FDG for detecting certain cancers Gallium-68-labeled FAPI tracer yields promising results
Dr. David Wong Professor recognized for contributions to PET and Theranostics
SVSR unveils Siemens Horizon PET/CT trailer Putting a small and powerful scanner on a coach
Philips to manage medical imaging equipment for Aussie providers for 20 years First-of-its-kind partnership in Australia and ASEAN Pacific region
BWXT developed a new medical isotope technology to produce Mo-99
“While neutron capture was the original method for producing Mo-99, Tc-99m generators using neutron capture Mo-99 historically produced a far less concentrated elution of Tc-99m,” Dr. Jonathan Cirtain, VP of advanced technologies at BWXT, told HCB News. “Therefore, [it] limited the types of kits and doses of imaging agent that could be effectively compounded, administered and imaged.”
Servicing GE Nuclear Medicine equipment with OEM trained engineers
We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED
However, the new technology produces a proprietary Mo-99 product that when eluted, produces an eluent of similar specific activity to fission-based Tc-99m generators that are available today. That means radiopharmacies can use BWXT Tc-99m generators in the same way they use current fission-based Tc-99m generators.
But Cirtain noted that unlike the traditional process of producing Mo-99 and Tc-99m generators from a nuclear fission process, this process doesn’t use fission. As a result, it doesn’t produce uranium or other fission products as waste, which is costly and difficult to dispose of and can be a proliferation concern.
BWXT expects this new medical isotope technology to provide a reliable domestic supply of Mo-99 and Tc-99m for North America. But the company has competition from a handful of companies with the same goal.
“We are confident because we have experience in this area developed over decades of work, and we’ve had a highly successful development program, including supplemental assistance from outside expertise when needed,” said Cirtain.
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
